1 |
Integrated xenosurveillance of Loa loa, Wuchereria bancrofti, Mansonella perstans and Plasmodium falciparum using mosquito carcasses and faeces: A pilot study in Cameroon.
62
|
Pryce J...Reimer L
|
36322515 |
2022 |
2 |
A large case series of travel-related Mansonella perstans (vector-borne filarial nematode): a TropNet study in Europe.
62
|
Tamarozzi F...Gobbi FG
|
35417002 |
2022 |
3 |
Loiasis from where you don't expect it: an illustrative case of misled diagnosis.
62
|
Nicolini AL...Gobbi FG
|
35532187 |
2022 |
4 |
Imported occult loiasis: diagnostic algorithm proposal for a difficult diagnosis.
62
|
Gerber V...Brunet J
|
35032386 |
2022 |
5 |
A call for loiasis to be added to the WHO list of neglected tropical diseases.
62
|
Jacobsen KH...Williams AS
|
35500592 |
2022 |
6 |
Misleading eosinophil counts in migration-associated malaria: do not miss hidden helminthic co-infections.
62
|
Castillo-Fernandez N...Salas-Coronas J
|
35934309 |
2022 |
7 |
Distinct loiasis infection states and associated clinical and hematological manifestations in patients from Gabon.
62
|
Veletzky L...Ramharter M
|
36121900 |
2022 |
8 |
The impact of Loa loa microfilaraemia on research subject retention during a whole sporozoite malaria vaccine trial in Equatorial Guinea.
62
|
Manock SR...Hoffman SL
|
35394038 |
2022 |
9 |
Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial.
62
|
Campillo JT...Chesnais C
|
34651190 |
2022 |
10 |
Comparison of three PCR-based methods to detect Loa loa and Mansonella perstans in long-term frozen storage dried blood spots.
62
|
Ta-Tang TH...Benito A
|
35653502 |
2022 |
11 |
Loa loa in the Vitreous Cavity of the Eye: A Case Report and State of Art.
62
|
Pallara E...Di Gennaro F
|
35914685 |
2022 |
12 |
Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d'Ivoire.
62
|
Ouattara AF...King CL
|
33674871 |
2022 |
13 |
Spleen nodules in Loa loa infection: re-emerging knowledge and future perspectives.
62
|
Tamarozzi F...Gobbi F
|
35219405 |
2022 |
14 |
Vector control and entomological capacity for onchocerciasis elimination.
62
|
Tirados I...Basanez MG
|
35379556 |
2022 |
15 |
Human Filariasis in Travelers and Migrants: A Retrospective 25-year Analysis at the Institute of Tropical Medicine, Antwerp, Belgium.
62
|
Bottieau E...Soentjens P
|
34463732 |
2022 |
16 |
Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections.
62
|
Greene SE...Weil GJ
|
35604906 |
2022 |
17 |
Colorimetric and Real-Time Loop-Mediated Isothermal Amplification (LAMP) for Detection of Loa loa DNA in Human Blood Samples.
62
|
Febrer-Sendra B...Muro A
|
35626235 |
2022 |
18 |
A novel series of putative Brugia malayi histone demethylase inhibitors as potential anti-filarial drugs.
62
|
Kreiss T...Siekierka J
|
35294431 |
2022 |
19 |
Lessons from Large-Scale Tolerability and Acceptability Studies of Triple Drug Mass Drug Administration Performed to Support Policy Change and Accelerate Elimination of Lymphatic Filariasis.
62
|
Weil GJ...Krentel A
|
35292585 |
2022 |
20 |
Atypical imported loiasis characterised by recurrent anaemia in a patient from China.
62
|
Luo X...Luo X
|
35092801 |
2022 |
21 |
Geostatistical modelling enables efficient safety assessment for mass drug administration with ivermectin in Loa loa endemic areas through a combined antibody and LoaScope testing strategy for elimination of onchocerciasis.
62
|
Johnson O...Diggle PJ
|
35139080 |
2022 |
22 |
Evaluation of LAMP for the diagnosis of Loa loa infection in dried blood spots compared to PCR-based assays and microscopy.
62
|
Ta-Tang TH...Benito A
|
35170676 |
2022 |
23 |
Loiasis and diurnal microfilaremia: searching at the right moment.
62
|
Musumeci S...Eperon G
|
34718684 |
2022 |
24 |
Loiasis is endemic in the Ndikinimeki Health District (Centre Region, Cameroon) but does not represent a hindrance to onchocerciasis elimination.
62
|
Sumo L...Nana Djeunga HC
|
34755644 |
2022 |
25 |
The Human Filaria Loa loa: Update on Diagnostics and Immune Response.
62
|
Dieki R...Akue JP
|
35936385 |
2022 |
26 |
Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi.
62
|
Zhan B...Lustigman S
|
35444961 |
2022 |
27 |
Current perspective of new anti-Wolbachial and direct-acting macrofilaricidal drugs as treatment strategies for human filariasis.
62
|
Ehrens A...Hubner MP
|
35463816 |
2022 |
28 |
Human filariasis-contributions of the Litomosoides sigmodontis and Acanthocheilonema viteae animal model.
62
|
Risch F...Hubner MP
|
33547508 |
2021 |
29 |
Evaluation of the in vitro susceptibility of various filarial nematodes to emodepside.
62
|
Hubner MP...Kulke D
|
34339934 |
2021 |
30 |
An Integrated District Mapping Strategy for Loiasis to Enable Safe Mass Treatment for Onchocerciasis in Gabon.
62
|
Ella SN...Atsame J
|
34781262 |
2021 |
31 |
Immunomodulatory Therapy for the Management of Loiasis.
62
|
Coyle C...Weiss LM
|
33326992 |
2021 |
32 |
A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa loa Infection.
62
|
Legrand F...Klion AD
|
32910141 |
2021 |
33 |
Loiasis.
62
|
Kalbitz S...Grunewald T
|
34449182 |
2021 |
34 |
'Slash and clear' vector control for onchocerciasis elimination and epilepsy prevention: a protocol of a cluster randomised trial in Cameroonian villages.
62
|
Siewe Fodjo JN...Njamnshi AK
|
34475178 |
2021 |
35 |
Diagnostic performance of capillary and venous blood samples in the detection of Loa loa and Mansonella perstans microfilaraemia using light microscopy.
62
|
Mischlinger J...Ramharter M
|
34398886 |
2021 |
36 |
Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update.
62
|
Chai JY...Hong SJ
|
34218593 |
2021 |
37 |
Unusual Localization of Blood-Borne Loa loa Microfilariae in the Skin Depends on Microfilarial Density in the Blood: Implications for Onchocerciasis Diagnosis in Coendemic Areas.
62
|
Niamsi-Emalio Y...Kamgno J
|
33909066 |
2021 |
38 |
Genome editing as control tool for filarial infections.
62
|
Kwarteng A...Ahuno ST
|
33581654 |
2021 |
39 |
A Case of Possible Loiasis Contracted in Cameroon and Diagnosed in Milan, Italy, and Review of Cases Published in Dermatological Journals.
62
|
Lunardon L...Veraldi S
|
34413738 |
2021 |
40 |
Serious adverse reactions associated with ivermectin: A systematic pharmacovigilance study in sub-Saharan Africa and in the rest of the World.
62
|
Campillo JT...Chesnais CB
|
33878105 |
2021 |
41 |
Preliminary comparison between an in-house real-time PCR vs microscopy for the diagnosis of Loa loa and Mansonella perstans.
62
|
Formenti F...Gobbi F
|
33484727 |
2021 |
42 |
Infection-associated Immune Perturbations Resolve 1 Year Following Treatment for Loa loa.
62
|
Herrick JA...Nutman TB
|
32055862 |
2021 |
43 |
IL-10 and Its Related Superfamily Members IL-19 and IL-24 Provide Parallel/Redundant Immune-Modulation in Loa loa Infection.
62
|
Ricciardi A...Nutman TB
|
32561912 |
2021 |
44 |
Diagnosis of Ocular Loiasis in a Patient from a Dirofilaria-Endemic Area.
62
|
Kumar A...Shashindran N
|
34431952 |
2021 |
45 |
An Adult Loa loa Worm in the Upper Eyelid: An Atypical Presentation of Loiasis in the United States.
62
|
Rodriguez L...Couser NL
|
33959400 |
2021 |
46 |
Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon.
62
|
Forrer A...Taylor MJ
|
33431378 |
2021 |
47 |
Computational Design and Preliminary Serological Analysis of a Novel Multi-Epitope Vaccine Candidate against Onchocerciasis and Related Filarial Diseases.
62
|
Shey RA...Souopgui J
|
33494344 |
2021 |
48 |
Validation of loop-mediated isothermal amplification for the detection of Loa loa infection in Chrysops spp in experimental and natural field conditions.
62
|
Amambo GN...Wanji S
|
33407819 |
2021 |
49 |
An Overview of the Management of Mansonellosis.
62
|
Ta-Tang TH...Rubio JM
|
34079424 |
2021 |
50 |
The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
62
|
Hosseini FS...Fathalipour M
|
33397429 |
2021 |